重组干扰素α2b雾化吸入在小儿毛细支气管炎治疗中的临床疗效观察

Abstract
Figure/Table
References (16)
Related Citation (0)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Recombinant Interferon α2b for aerosol inhalation in the treatment of bronchiolitis in children.Methods A total of 80 cases of children with bronchiolitis treated in our hospital from October 2019 to January 2020 were selected as the research objects.According to the principle of random control,they were divided into the control group and the observation group, 40 cases in each group.The control group was given Budesonide + Terbutaline Atomization treatment, and the observation group was given Recombinant Interferon α2b for aerosol inhalation treatment on the basis of the control group.The clinical efficacy, the disappearance time of related symptoms, hospitalization time and hospitalization expenses were compared between the two groups.Results The total effective rate of the observation group was 100.00%, which was higher than 85.00% of the control group, there was significant difference (P＜0.05).The disappearance time of fever, cough, panting, wheezing rale, moist rale of the observation group were shorter than those of the control group, and the differences were significant (P＜0.05).The hospitalization time of the observation group was shorter than that of the control group, and the hospitalization cost of the observation group was lower than that of the control group, and the differences were significant (P＜0.05).Conclusion Recombinant interferon α2b for aerosol inhalation has a good clinical effect in the treatment of bronchiolitis in children, which can improve the clinical symptoms of children and shorten the disappearance time of symptoms in children.

Key words： Recombinant Interferon α2b Aerosol inhalation Pediatric bronchiolitis Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI De-you
	XU Jing-huai
	LIU Ming-feng

Cite this article:

LI De-you,XU Jing-huai,LIU Ming-feng. Clinical efficacy observation of Recombinant Interferon α2b for aerosol inhalation in the treatment of bronchiolitis in children[J]. 中国当代医药, 2020, 27(22): 121-123.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I22/121

[1]	何丽丹，吴铁峰，蔡振荡.FeNO 检测用于指导毛细支气管炎患儿糖皮质激素治疗的临床研究[J].现代实用医学，2019，31（11）：1493-1494，1500.
[2]	方振华.布地奈德联合沙丁胺醇治疗小儿毛细支气管炎的效果和安全性观察[J].中国社区医师，2019，35（32）：28，30.
[3]	曹文琪.布地奈德联合异丙托溴铵治疗小儿毛细支气管炎的临床效果[J].医学理论与实践，2019，32（20）：3330，3345.
[4]	陈荣钦.盐酸氨溴索、布地奈德辅助治疗小儿毛细支气管炎的效果对比[J].黑龙江医药，2019，32（5）：1057-1059.
[5]	卫志莲.氨溴索联合布地奈德雾化吸入治疗小儿毛细支气管炎的临床效果[J].中国当代医药，2019，26（29）：103-105.
[6]	胡亚美，江载芳.诸福棠实用儿科学（第8 版）[M].北京：人民卫生出版社，2012：15-16.
[7]	Kim J，Kim MJ，Sol IS，et al.Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans[J].PLoS One，2019，14（4）：e0214647.
[8]	元国红.中西医联合治疗小儿毛细支气管炎痰热闭肺证疗效分析[J].深圳中西医结合杂志，2019，29（19）：26-27.
[9]	史恪勤.重组人干扰素α-2b 雾化联合射干麻黄汤治疗小儿毛细支气管炎临床研究[J].新中医，2019，51（10）：200-203.
[10]	黄学晓，张世民，罗旋.干扰素α-2b 治疗小儿呼吸道合胞病毒毛细支气管炎的疗效及对患儿血清SP-D、TGFβ 及IL-4 水平的影响[J].解放军预防医学杂志，2019，37（7）：172-173.
[11]	赵小阳.雾化吸入重组人干扰素α-2b 治疗小儿毛细支气管炎的治疗剂量、安全性和有效性分析[J].中国社区医师，2019，35（18）：7-8.
[12]	李文辉，贾彬，刘俊莹.重组干扰素α2b 雾化治疗小儿毛细支气管炎的疗效及对免疫功能的影响[J].中国现代医学杂志，2019，29（24）：1-9.
[13]	高雅松，程贤高.重组人干扰素α-2b 在小儿毛细支气管炎中的应用[J].现代诊断与治疗，2019，30（6）：959-960.
[14]	黄亚平，牛文泽，黄卫良，等.重组干扰素α2b 联合布地奈德、异丙托溴铵雾化治疗小儿毛细支气管炎疗效观察[J].解放军医学院学报，2018，39（8）：688-690，722.
[15]	沙帮武，李永玉，江慧星.重组人干扰素α-2b 注射液氧气驱动雾化吸入治疗小儿毛细支气管炎疗效观察[J].现代诊断与治疗，2018，29（4）：616-617.
[16]	曾静好，黎进飞，赖永艺，等.重组人干扰素α-2b 注射液雾化吸入治疗小儿毛细支气管炎的疗效观察[J].吉林医学，2016，37（6）：1319-1321.